Bain Capital and Cinven to Acquire Lonza Specialty Ingredients

February 8, 2021

Bain Capital Private Equity and Cinven have entered into definitive agreements to acquire Lonza Specialty Ingredients (LSI), a division of Lonza AG, for a total enterprise value of CHF 4.2 billion. LSI, headquartered in Basel, Switzerland, is a global provider of specialty chemicals for microbial control with ~2,800 employees, and the consortium intends to invest in R&D, bolster production capabilities and use LSI as a platform for buy-and-build consolidation in the sector; the transaction was expected to close in H2 2021.

Buyers
Bain Capital Private Equity, Cinven
Targets
Lonza Specialty Ingredients
Sellers
Lonza AG
Industry
Manufacturing
Location
Basel-Stadt, Switzerland
Transaction Type
Divestiture

Explore More

Related Acquisitions

Track M&A activity that matters to you

Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.